期刊文献+

中药对心肌缺血再灌注损伤过程中自噬的调控 被引量:15

Regulatory effects of traditional Chinese medicine on autophagy in myocardial ischemia reperfusion injury
原文传递
导出
摘要 自噬是一种利用溶酶体来清除细胞内不必要或受损的细胞器,以维持细胞内环境稳态的基本过程。近年来的研究表明,自噬在心肌缺血再灌注过程中发挥着重要的作用。在心肌缺血阶段,适度的自噬可以保护细胞免受各种压力;然而在再灌注阶段时,过度的自噬使细胞死亡进一步增强。因此,自噬在心肌缺血再灌注过程中具有的双重作用为心脏疾病的治疗提供了新的治疗靶点。近年来,越来越多的中药被证实可以通过调节心肌细胞的自噬水平,通过增强自噬或抑制自噬,对受损心肌产生保护作用。该文综述了心肌缺血再灌注损伤过程中自噬的主要分子机制和作用及中药对其的调控作用。 Autophagy is a basic process of eliminating unnecessary or damaged organelles by lysosome to maintain the internal envi- ronment homeostasis. Recent studies have revealed that autophagy plays an important role in pathology of myocardial ischemia reperfu- sion. In the phase of ischemia, moderate autophagy can protect the cells against various stress; but in the phase of reperfusion, exces- sive autophagy can increase the death of cells. Therefore, the dual role of autophagy in myocardial ischemia reperfusion provides a new therapeutic target for the treatment of heart disease. In recent years, more and more Chinese medicines have been proved to adjust the autophagy in myocardial cells, and protect the damaged myocardium by enhancing or inhibiting autophagy. This article would review the molecular mechanisms of autophagy and its role in myocardial ischemia reperfusion injury as well as the regulation effect of Chinese medicine on it.
作者 郑晴 包怡敏
出处 《中国中药杂志》 CAS CSCD 北大核心 2017年第15期2925-2929,共5页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(81303256 81202945)
关键词 中药 心肌缺血再灌注 自噬 traditional Chinese medicine myocardial ischemia-reperfusion autophagy
  • 相关文献

参考文献14

二级参考文献88

  • 1Michael Rahbek Schmidt,Kasper Pryds,Hans Erik Btker.Novel adjunctive treatments of myocardial infarction[J].World Journal of Cardiology,2014,6(6):434-443. 被引量:10
  • 2赵外欧,李相军.NF-κB参与银杏叶提取物保护血管内皮细胞的作用[J].中国老年学杂志,2015,35(1):178-179. 被引量:9
  • 3王保和 ,傅伟 ,李竹庭 .丹酚酸B对急性心肌缺血/再灌注损伤大鼠心肌保护作用的机制研究[J].天津中医学院学报,2004,23(3):132-133. 被引量:12
  • 4孙丽红,李鸿珠,韩丽萍,姜春明,赵雅君,高秀香,田野,徐长庆.青蒿素对离体大鼠心肌缺血/再灌注损伤的保护作用[J].中国中药杂志,2007,32(15):1547-1551. 被引量:9
  • 5苗明三,王升启.现代方剂学[M].北京:清华大学出版社,2004:1621,1718.
  • 6Bowden DW,Cox AJ, Freedman BI, et al. Review of the Dia- betes Heart Study(DHS) family of studies:a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its eomplications[J]. Rev Diabet Stud, 2010,7(3) : 188-201.
  • 7Stratton IM,Cull CA, Adler AI,et al. Additive effects of gly- caemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study(UKPDS 75 ) [-J']. Diabetologia, 2006,49 (8) : 1761-1769.
  • 8Nathan DM,Cleary PA,Backlund JY,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes[J]. N Engl J Med,2005,353(25) :2643-2653.
  • 9ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J~. N Engl J Med, 2008,358 (24) :2560-2572.
  • 10Renaud S, Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease [J~. Lancet, 1992, 339 (8808) : 1523-1526.

共引文献200

同被引文献193

引证文献15

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部